C. West

发表

A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.

M. Sydes, D. Dearnaley, P. Pharoah, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Establishment of a radiogenomics consortium.

Barry S Rosenstein, B. Rosenstein, C. West, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The potential of PET to increase understanding of the biological basis of tumour and normal tissue response to radiotherapy

C. West, N. Charnley, Catharine M L West, 2005 .

Meta-GWAS identifies the heritability of acute radiation-induced toxicities in head and neck cancer.

R. Steenbakkers, J. Dennis, A. Crijns, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancer

J. Chang-Claude, K. Haustermans, P. Seibold, 2022, Frontiers in Oncology.

The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE study.

Tim E. Ward, J. Chang-Claude, P. Seibold, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Apoptosis as predictor of response to radiotherapy in cervical carcinoma

S. Roberts, C. Potten, C. West, 1994, The Lancet.

Reirradiation Options for Previously Irradiated Prostate cancer (RO-PIP): Feasibility study investigating toxicity outcomes following reirradiation with stereotactic body radiotherapy (SBRT) versus high-dose-rate brachytherapy (HDR-BT)

D. Buckley, A. Scarsbrook, P. Hoskin, 2022, BMJ Open.

Prediction of cervical carcinoma response to radiotherapy

S. Davidson, C. West, J. Hendry, 1991, The Lancet.

Guidelines for using sigQC for systematic evaluation of gene signatures

Wei-Chen Cheng, Tim Maughan, Jacob G Scott, 2019, Nature Protocols.

Genomic analysis of male puberty timing highlights shared genetic basis with hair colour and lifespan

K. D. Sørensen, Ali Amin Al Olama, A. Auton, 2020, Nature Communications.

Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

K. D. Sørensen, Ali Amin Al Olama, Lilit C Moss, 2021, Nature Genetics.

Predicting tumour radiosensitivity to deliver precision radiotherapy

C. West, J. Price, Asmithaa Prabhakaran, 2022, Nature Reviews Clinical Oncology.

Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants

K. D. Sørensen, Ali Amin Al Olama, H. Ostrer, 2018, Nature Communications.

Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer

K. D. Sørensen, O. Andreassen, A. Dale, 2021, Prostate Cancer and Prostatic Diseases.

An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk

K. D. Sørensen, Ali Amin Al Olama, Jason B. Nikas, 2020, Nature Communications.

Author Correction: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma

K. D. Sørensen, Ali Amin Al Olama, D. Gudbjartsson, 2019, Nature Communications.

Effect of Race and Ethnicity on Risk of Radiotherapy Toxicity and Implications for Radiogenomics.

C. West, N. Burnet, A. Choudhury, 2022, Clinical oncology (Royal College of Radiologists (Great Britain)).

Impact of hypoxia on cervical cancer outcomes

P. Hoskin, A. Choudhury, C. West, 2021, International Journal of Gynecological Cancer.

Predictive Assays in Radiation Therapy

C. West, 1994 .

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

K. D. Sørensen, Ali Amin Al Olama, H. Ostrer, 2019, Nature Genetics.

Will SNPs be useful predictors of normal tissue radiosensitivity in the future?

M. Parliament, E. Dikomey, C. Andreassen, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study.

Tim E. Ward, J. Chang-Claude, P. Seibold, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Use of Angiotensin Converting Enzyme Inhibitors is Associated with Reduced Risk of Late Bladder Toxicity Following Radiotherapy for Prostate Cancer.

Tim E. Ward, J. Chang-Claude, E. Messing, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity

J. Chang-Claude, A. Dunning, R. Stock, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Establishment of a Radiogenomics Consortium.

Andrzej Polanski, Karin Haustermans, Barry Rosenstein, 2010, International journal of radiation oncology, biology, physics.

Author Correction: Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility

K. D. Sørensen, Ali Amin Al Olama, M. Kogevinas, 2019, Nature Communications.

Requite: Validating Predictive Models and Biomarkers of Radiotherapy Toxicity to Reduce Side-Effects and Improve Quality-of-Life in Cancer Survivors

J. Chang-Claude, P. Seibold, D. Ruysscher, 2019, International Journal of Radiation Oncology*Biology*Physics.

Large-scale transcriptome-wide association study identifies new prostate cancer risk regions

Alexander Gusev, Bogdan Pasaniuc, K. D. Sørensen, 2018, Nature Communications.

Prediction of radiotherapy response using SF2: is it methodology or mythology?

C. West, J. Hendry, 1994, Radiotherapy and Oncology.

Molecular markers predicting radiotherapy response: report and recommendations from an International Atomic Energy Agency technical meeting.

Michael Baumann, Karin Haustermans, Jolyon H Hendry, 2005, International journal of radiation oncology, biology, physics.

TORPEdO: A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer

E. Miles, C. Nutting, J. Langendijk, 2022, Clinical and translational radiation oncology.

Hypoxia Is Associated with Increased Immune Infiltrates and Both Anti-Tumour and Immune Suppressive Signalling in Muscle-Invasive Bladder Cancer

P. Hoskin, T. Illidge, A. Choudhury, 2023, International journal of molecular sciences.

Hypoxia does not predict lack of benefit from adjuvant radiotherapy for patients with early stage breast cancer

C. West, 2022, British Journal of Cancer.

Normal Tissue Toxicity Prediction: Clinical Translation on the Horizon.

B. Marples, S. Kerns, C. West, 2023, Seminars in radiation oncology.

Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study).

Tim E. Ward, J. Chang-Claude, A. Dunning, 2022, Lung Cancer.

Association analyses identify 31 new risk loci for colorectal cancer susceptibility

K. D. Sørensen, Aung Ko Win, I. Deary, 2019, Nature Communications.

Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer

P. Boutros, D. Neal, R. Bristow, 2018, EBioMedicine.

The genomics revolution and radiotherapy.

N G Burnet, N. Burnet, R. Elliott, 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

Association analyses identify 31 new risk loci for colorectal cancer susceptibility

K. D. Sørensen, Aung Ko Win, I. Deary, 2019, Nature Communications.

Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma

K. D. Sørensen, Ali Amin Al Olama, D. Gudbjartsson, 2018, Nature Communications.

Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility

Karl-Heinz Jöckel, Julian Peto, K. D. Sørensen, 2017, Nature Communications.

Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis

K. D. Sørensen, H. Grönberg, E. Riboli, 2023, Diabetologia.

(Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer

Tim E. Ward, J. Chang-Claude, P. Seibold, 2023, International journal of cancer.

Contouring variation affects estimates of normal tissue complication probability for breast fibrosis after radiotherapy

Maria Carmen De Santis, P. Seibold, D. Ruysscher, 2023, Breast.

Comparison of multiple gene expression platforms for measuring a bladder cancer hypoxia signature.

H. Denley, B. Lane, A. Choudhury, 2022, Molecular medicine reports.

The intrinsic radiosensitivity of normal and tumour cells.

J H Hendry, J. Hendry, S. Roberts, 1998, International journal of radiation biology.

Germline variation at 8q24 and prostate cancer risk in men of European ancestry

K. D. Sørensen, H. Ostrer, T. Sellers, 2018, Nature Communications.

Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis

K. D. Sørensen, A. Tardón, R. Eeles, 2024, EBioMedicine.

Comparison of prone and supine positioning for breast cancer radiotherapy using REQUITE data: dosimetry, acute and two years physician and patient-reported outcomes

P. Seibold, D. de Ruysscher, S. Gutiérrez‐Enríquez, 2023, Acta oncologica.

Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants

K. D. Sørensen, Jacob M. Keaton, R. Mägi, 2023, Nature Genetics.

The REQUITE Project: Validating predictive models and biomarkers of radiotherapy toxicity to reduce side-effects and improve quality of life in cancer survivors.

P. Lambin, D. Ruysscher, S. Gutiérrez‐Enríquez, 2016 .